促红细胞生成素对糖尿病心肌病保护作用的研究进展  

Research Progress on Protective Effect of Erythropoietin on Diabetic Cardiomyopathy

作　　者：牟娇 张新金[2] MOU Jiao 1 ,ZHANG Xinjin 2(1.The Fourth Affiliated Hospital of Kunming Medical University,Kunming 650000,Yunnan,China; 2.Department of Cardiology,The Second People s Hospital of Yunnan Province,Kunming 650000,Yunnan,Chin)

机构地区：[1]昆明医科大学第四附属医院,云南昆明650000 [2]云南省第二人民医院,云南昆明650000

出　　处：《心血管病学进展》2018年第5期819-822,共4页Advances in Cardiovascular Diseases

摘　　要：糖尿病心肌病是指发生于糖尿病患者,有心脏结构和功能的改变,而不能用高血压性心脏病、冠心病、心脏瓣膜病及其他心脏病变来解释的一种心肌疾病。目前有许多关于糖尿病心肌病的作用机制及治疗方面的研究。现主要对糖尿病心肌病作用机制及促红细胞生成素对糖尿病心肌病的保护作用做一综述。Diabetic cardiomyopathy describes diabetes-associated changes in the structure and function of the myocardium that cannot be explained by hypertensive heart disease,coronary atherosclerotic heart disease,valvular heart disease and other cardiac diseases.There were many studies on the mechanisms and treatment of diabetic cardiomyopathy.The mechanisms of diabetic cardiomyopathy and the protective effects of erythropoietin on diabetic cardiomyopathy are reviewed in this paper.

关 键 词：糖尿病心肌病 促红细胞生成素 自噬 细胞凋亡 

分 类 号：R587.1[医药卫生—内分泌] R542.2[医药卫生—内科学]